Vindesine, cisplatin, and bleomycin combination chemotherapy in non-small cell lung cancer: survival and quality of life
- 1 August 1986
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 22 (8), 963-970
- https://doi.org/10.1016/0277-5379(86)90063-5
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: A randomized studyEuropean Journal of Cancer and Clinical Oncology, 1984
- A randomized prospective study of vindesine versus doxorubicin and cyclophosphamide in the treatment of epidermoid lung cancerCancer, 1983
- Efficacy study of intensive cis-platin therapy in advanced non-small cell bronchogenic carcinomaCancer, 1982
- Vindesine in bronchogenic carcinomaAmerican Journal of Clinical Oncology, 1982
- Clinical pharmacokinetics of vindesineCancer Chemotherapy and Pharmacology, 1979
- Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular CancerAnnals of Internal Medicine, 1977
- Bleomycin combination chemotherapy in the management of testicular neoplasiaCancer, 1975
- A clinical review of bleomycin—a new antineoplastic agentCancer, 1973
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- The use of the nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinomaCancer, 1948